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ABSTRACT
Genetic and phylogenetic analyses suggest that the pandemic H1N1/2009 virus was derived fromwell-established swine influ-
enza lineages; however, there is no convincing evidence that the pandemic virus was generated from a direct precursor in pigs.
Furthermore, the evolutionary dynamics of influenza virus in pigs have not been well documented. Here, we subjected a recom-
binant virus (rH1N1) with the same constellation makeup as the pandemic H1N1/2009 virus to nine serial passages in pigs. The
severity of infection sequentially increased with each passage. Deep sequencing of viral quasispecies from the ninth passage
found five consensus amino acid mutations: PB1 A469T, PA 1129T, NAN329D, NS1 N205K, and NEP T48N. Mutations in the
hemagglutinin (HA) protein, however, differed greatly between the upper and lower respiratory tracts. Three representative viral
clones with the five consensus mutations were selected for functional evaluation. Relative to the parental virus, the three viral
clones showed enhanced replication and polymerase activity in vitro and enhanced replication, pathogenicity, and transmissibil-
ity in pigs, guinea pigs, and ferrets in vivo. Specifically, two mutants of rH1N1 (PB1 A469T and a combination of NS1 N205K and
NEP T48N) were identified as determinants of transmissibility in guinea pigs. Crucially, one mutant viral clone with the five con-
sensus mutations, which also carried D187E, K211E, and S289Nmutations in its HA, additionally was able to infect ferrets by
airborne transmission as effectively as the pandemic virus. Our findings demonstrate that influenza virus can acquire viral char-
acteristics that are similar to those of the pandemic virus after limited serial passages in pigs.
IMPORTANCE
We demonstrate here that an engineered reassortant swine influenza virus, with the same gene constellation pattern as the
pandemic H1N1/2009 virus and subjected to only nine serial passages in pigs, acquired greatly enhanced virulence and
transmissibility. In particular, one representative pathogenic passaged virus clone, which carried three mutations in the
HA gene and five consensus mutations in PB1, PA, NA, NS1, and NEP genes, additionally was able to confer respiratory
droplet transmission as effectively as the pandemic H1N1/2009 virus. Our findings suggest that pigs can readily induce
adaptive mutational changes to a precursor pandemic-like virus to transform it into a highly virulent and infectious form
akin to that of the pandemic H1N1/2009 virus, which underlines the potential direct role of pigs in promoting influenza A
virus pathogenicity and transmissibility.
In March and early April 2009, a novel H1N1 influenza A virus(IAV) emerged in Mexico and the United States and rapidly
triggered the first human pandemic of the 21st century (1). Phy-
logenetic and genetic studies revealed that the eight-gene seg-
ments of the H1N1/2009 virus were generated through reassort-
ment between well-established swine influenza lineages, the
Eurasian avian-like lineage, and the North American triple-reas-
sortant lineage (1–3). Furthermore, structural and serological
studies of its hemagglutinin (HA) have demonstrated that the
H1N1/2009 virus is antigenically similar to 1918-like and classical
swine H1N1 viruses (4, 5). Phylogenetically, the H1N1/2009 virus
corresponds to a genetic ancestry of swine viruses, suggesting ei-
ther an increased evolutionary rate or a long but unnoticed period
of circulation in pigs prior to its 2009 pandemic emergence.
Bayesian molecular clock analysis demonstrated that the evolu-
tionary rate preceding the H1N1/2009 virus pandemic was typical
for swine influenza (2). Thus, the reassortment of Eurasian avian-
like and North American triple-reassortant swine lineages may
not have occurred just before the 2009 pandemic; instead, a single
reassortant (pandemic H1N1-like) virus may have been crypti-
cally circulating in an unidentified host species for years before the
outbreak in humans (2, 3). However, the reassortment dynamics
of H1N1/2009 virus have not been determined in swine or hu-
mans by epidemiological surveillance (2, 6).
In our earlier study, we constructed a reassortant swine
H1N1 influenza virus (rH1N1) with the same phylogenetic
gene combination as the pandemic H1N1/2009 virus. The
neuraminidase (NA) and matrix (M) gene segments were from
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a Eurasian avian-like H1N1 swine influenza virus, and the
other six genes were from a triple-reassortant H1N2 swine in-
fluenza virus (7). Unlike the pandemic H1N1/2009 virus, we
found that this H1N1/2009-like virus is not able to confer virus
transmissibility in guinea pigs, and that additional amino acid
mutations are needed to make the virus as transmissible as the
pandemic IAV (7). Consequently, the question remains: can
IAVs acquire the characteristics of H1N1/2009 virus, including
specific amino acid mutations of the H1N1/2009 virus, after
undergoing adaptive changes in a specific host?
Thus far, adaptive changes of IAVs have been studied mainly
by serial viral passages in laboratory species (8, 9). Mice have been
used extensively for investigating pathogenic mechanisms and
host range determinants (10, 11). Guinea pigs and ferrets support
IAV transmission and have been used as models for IAV adapta-
tion studies (12–16). Pigs, on the other hand, can be naturally or
experimentally infected with IAVs. They can serve as mixing ves-
sels or intermediate hosts for the generation of novel reassortant
viruses (17, 18). Therefore, pigs most likely perform key roles in
the evolutionary process of influenza viruses and in their cross-
species transmission (19, 20). The emergence of the H1N1/2009
virus provides further evidence of the role of pigs in the influenza
virus ecosystem. However, there is no direct supporting evidence
to show that the pandemic H1N1/2009 virus was derived from
pigs. Thus, it is important to investigate the adaptive evolution of
IAVs in pigs.
To explore the evolutionary genesis of the pandemic H1N1/
2009 virus, we performed serial passages of the rH1N1 construct
in pigs and examined its sequential replication, pathogenicity, and
transmissibility. By the ninth passage, the resulting viral popula-
tion with five consensus mutations had acquired marked patho-
genicity and in-contact transmissibility in swine and guinea pigs.
Moreover, one particular representative viral clone, with three
additional HA mutations, also acquired the ability for efficient
airborne transmission between ferrets.
MATERIALS AND METHODS
Ethics statement. All animal research was approved by the Beijing Asso-
ciation for Science and Technology (approval identifier [ID] SYXK [Bei-
jing] 2007-0023) and performed in compliance with the Beijing Labora-
tory Animal Welfare and Ethics guidelines, as issued by the Beijing
Administration Committee of Laboratory Animals, and in accordance
with the China Agricultural University (CAU) Institutional Animal Care
and Use Committee guidelines (ID SKLAB-B-2010-003) approved by the
Animal Welfare Committee of CAU.
Viruses and cells. The parental rH1N1 virus was described previously
and was generated by reverse genetics (7), in which the NA and M genes
from A/Swine/Fujian/204/2007 (accession numbers FJ536810 to
FJ536817) and the other six genes from A/Swine/Guangdong/1222/2006
(accession numbers GU086078 to GU086085) were from the same phy-
logenetic cluster of H1N1/2009 viruses. The pandemic H1N1/2009 virus,
A/Swine/Shandong/731/2009 (SD731), was isolated from swine in Shan-
dong Province, China, in December 2009. Its complete genomic sequence
is available in GenBank (accession numbers JF951848 to JF951855). Vi-
ruses were titrated in MDCK cells to determine the median tissue culture
infectious dose (TCID50) by the Reed and Muench method (21). MDCK
cells and A549 human lung adenocarcinoma cells were maintained in
Dulbecco’s modified Eagle’s medium (DMEM; Gibco) containing 10%
fetal bovine serum (FBS; Gibco) and 1% antibiotics (Invitrogen). In vivo
and in vitro experiments involving rH1N1 and H1N1/2009 viruses were
conducted in biosafety level (BSL) 2 containment, as approved by the
Ministry of Agriculture of China and the China National Accreditation
Service for Conformity Assessment.
Serial passages, clinical measurements, and sampling. Landrace hy-
brid pigs, aged 4 to 5weeks at the outset, were sourced from a high-health-
status herd (porcine reproductive and respiratory syndrome [PRRS] virus
free) andwere IAV and antibody (H1,H3,H5,H7, andH9) negative byM
gene PCR and hemagglutination inhibition assays prior to the start of the
study. Passaging was established initially in one pig by intranasal inocula-
tion with a total dose of 106 TCID50 rH1N1 virus, delivered in a final
volume of 2.5 ml per nostril, using a mucosal atomization device (MAD;
Wolfe Tory Medical, Inc.) to mimic aerogenic infection. The animal was
euthanized at 4 days postinoculation (dpi). The lung was removed whole
and lavaged with 200ml phosphate-buffered saline (PBS) to obtain bron-
choalveolar lavage fluid (BALF), and the nasal wash was performed with
10 ml PBS (containing 1% antibiotics). Five ml BALF and two ml nasal
wash were combined to infect the next pig. The remaining nasal wash,
BALF, and the collected tissue samples of each passage were stored at
80°C. During each passage, veterinary assessment wasmade at two fixed
time points daily. Clinical parameters determined were rectal tempera-
ture, appetite, mental changes, bilateral nasal and ocular discharges,
wheezing, and coughing.
Gross and microscopic examination of lung lesions. During nec-
ropsy, a mean value of the percentage of gross lesions (defined as dark red
consolidation) was calculated for the pulmonary lobes. The lung tissue
was collected and fixed in 10% phosphate-buffered formalin for histo-
pathological examination, which was performed as described previously
(22). Tissue sections of lungs were stained with hematoxylin and eosin
(H&E) and examined microscopically for bronchiolar epithelial changes
and peribronchiolar inflammation. Lesion severity was scored by the dis-
tribution or by the extent of lesions within the sections examined (22)
with the following scale: 0, no visible changes; 1, mild focal ormultifocal
change; 2, moderate multifocal change; 3, moderate diffuse change;
4, severe diffuse change. Two independent pathologists scored all slides
from blinded experimental groups.
Deep sequencing.Viral RNAwas extracted fromnasalwash andBALF
of the pigs after nine serial passages with the parental rH1N1 virus using
the High Pure RNA isolation kit (Roche). RNA was subjected to reverse
transcription-PCR (RT-PCR) using 18 primer sets that cover the entire
viral genome. These primer sets were designed according to the genome
sequences of the rH1N1 virus and by using Primer Premier 5.0 software.
The fragments, approximately 600 to 800 nucleotides in length, were se-
quenced using the Illumina HiSeq2000 sequencing platform in the Chi-
nese National Human Genome Center, Shanghai. Briefly, a library was
constructedwith TruSeqDNA sample prep kit set A. TheDNA librarywas
diluted and hybridized to the paired-end sequencing flow cells. DNA clus-
ters were generated on a cBot cluster generation system with the TruSeq
PE cluster generation kit v2, followed by sequencing on a HiSeq 2000
system with the TruSeq SBS kit v2. The threshold for the detection of
single-nucleotide polymorphisms (SNP) was set manually at 10% of the
population.
Sanger sequencing.GenomeRNAsof viral cloneswere extracted from
culture supernatants using the QIAamp viral RNA kit (Qiagen). Genes
were reverse transcribed and amplified using a OneStep RT-PCR kit
(Qiagen). Primers were the same as those used in the deep sequencing
assay. The amplified cDNA products were excised from agarose gels and
purified using aQIAquick gel extraction kit (Qiagen). Full-genomeDNAs
were Sanger sequenced by Huada Zhongsheng Scientific Corporation,
and the sequence data were analyzed using GenScan software.
Viral growth kinetics. Confluent MDCK or A549 cells were infected
with L2, N9, L18, or parental rH1N1 virus at a multiplicity of infection
(MOI) of 0.001 in serum-free DMEM containing 2 mg/ml tolylsulfonyl
phenylalanyl chloromethyl ketone (TPCK)-trypsin (Sigma-Aldrich) and
were cultured in a 37°C CO2 incubator. Cell supernatants were harvested
every 12 h until 72 h postinoculation (hpi) and titrated by the TCID50
method on MDCK cells.
Wei et al.
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Western blotting.MDCK cells infected with L2, N9, L18, or parental
rH1N1 virus were collected at 12 or 24 hpi. The protein samples derived
from cell lysates were heated at 100°C for 5 min and then separated on a
10% sodiumdodecyl sulfate-polyacrylamide gel and transferred to a poly-
vinylidene difluoride (PVDF) membrane (Bio-Rad). Membranes were
incubatedwithmouse anti-NPmonoclonal antibody (Abcam) and horse-
radish peroxidase (HRP)-conjugated rabbit anti-goat IgG (GE Health-
care, Inc.). The membranes were developed with an enhanced chemilu-
minescence kit (Pierce).
Polymerase activity assay. A combination of wild-type or mutant
PB2, PB1, PA, and NP expression plasmids (125 ng each) was cotrans-
fected into 293T cells with the luciferase reporter plasmid pYH-Luci (10
ng) and internal control plasmid renilla (5 ng). At 24 h posttransfection, a
luciferase assay was performed using the Dual-Luciferase reporter assay
system (Promega) and read using a GloMax 96 microplate luminometer
(Promega).
Generation of mutant viruses by reverse genetics. RT-PCR-derived
mutant viral genes were cloned into a dual-promoter plasmid, pHW2000.
MDCK and 293T cells (1:2 mixture) were cocultured in 6-well plates and
transfected with 0.5 g of each of the eight plasmids and 10 l Lipo-
fectamine 2000 (Invitrogen) in a total volume of 1 ml of Opti-MEM (In-
vitrogen) into each well. After incubation at 37°C for 6 h, the transfection
mixture was removed from the cells and 2 ml of Opti-MEM containing 1
mg/ml of TPCK-trypsin was added. After 48 h, the supernatant was used
to inoculate MDCK cells (cultured in a T75 flask) to produce stock virus.
Viral RNAwas extracted and analyzed byRT-PCR, and each viral segment
was sequenced to confirm the identity of the virus. Stock viruses were
titrated by the TCID50 method on MDCK cells.
Infection and transmission in pigs. Twelve Landrace hybrid pigs,
aged 4 to 5 weeks, were randomly assigned into four separate groups of
three. All pigs were sourced from a high-health-status herd (PRRS virus
free and IAV and antibody negative). Each pig was infected intranasally
with a total dose of 106 TCID50 test virus delivered in a final volume of 2.5
ml per nostril. Three naive animals were introduced into each cage 24 h
later. Beginning at 1 dpi, nasal swabs were collected daily and titrated on
MDCK cells. The clinical symptoms of each pig were recorded daily. The
directly infected pigs were euthanized at 6 dpi, and the contact pigs were
euthanized at 7 days postcontact (dpc). Lungs were removed for viral load
assessment and histopathology.
Contact transmission in guinea pigs. FemaleHartley strain SPF/VAF
guinea pigs (serologically negative for IAVs) that weighed between 300
and 350 g were obtained from Vital River Laboratories. They were anes-
thetized by intramuscular injection of Zoletil 100 (tiletamine-zolazepam;
10 to 15 mg/kg of body weight; Virbac) prior to all handling procedures,
including inoculation, nasal washes, and collection of blood. Three guinea
pigs each were intranasally inoculated with a dose of 106 TCID50 of a
specific virus in 200 l PBS. Each inoculated animal was placed in a new
cage with one naive guinea pig at 1 dpi. Nasal washes were collected from
all six guinea pigs at 2, 4, 6, 8, and 10 dpi. The ambient conditions for this
study were set at 20 to 25°C and 30% to 40% relative humidity.
Respiratory droplet transmission in ferrets. Six- to twelve-month-
old male Angora ferrets (Angora Ltd.), serologically negative by the hem-
agglutination inhibition assay for currently circulating influenza viruses
(H1, H3, H5, H7, and H9), were used. At the start of the experiment, all
ferrets were greater than 1.0 kg (range, 1.12 to 1.58 kg) in weight. Ferrets
that lost more than 25% of their body weight or exhibited neurological
dysfunction were euthanatized and submitted to postmortem examina-
tion. Baseline rectal temperature andweightmeasurementswere obtained
prior to infection. Groups of three ferrets were intranasally inoculated
with 106 TCID50 of test virus and housed in specially designed cages inside
an isolator. At 1 dpi, three naive animals were placed in an adjacent cage (5
cm away), separated by a double-layered net divider that allowed free
passage of air. Nasal washes were collected at 2-day intervals beginning at
2 dpi (1 day postexposure [dpe]) and were titrated in MDCK cells. Di-
rectly infected and exposed ferrets were euthanized at 8 dpi and 9 dpe,
respectively. The ambient conditions for these studies were set at 20 to
25°C and 30% to 40% relative humidity. The horizontal airflow in the
isolator was at 0.1 m/s and was directed from the inoculated to exposed
animals.
Statistical analyses. Statistically significant differences between exper-
imental groups were determined using the analysis of variance (ANOVA)
method. A P value of0.05 was considered statistically significant.
RESULTS
rH1N1 virus showed enhanced pathogenicity after nine pas-
sages in pigs.To study the natural evolution of a virus that has the
same gene combination as the pandemic H1N1/2009 virus, we
passaged the rH1N1 virus (7) in pigs by one-on-one delivery. Pas-
saging began with the nasal inoculation of 106 TCID50 of the
rH1N1 virus. Clinical signs were monitored daily until 4 dpi, at
which time the animal was euthanized to collect nasal wash and
BALF. The mixture of the nasal wash (2 ml) and BALF (5 ml)
subsequently was used to inoculate the next pig intranasally (pas-
sage 2 [P2]). This procedure was repeated until P9.
Overall, the clinical signs elicited from P1 to P9 virus-infected
pigs increased steadily from mild to severe. The P1 and P2 virus-
infected pigs did not show any overt clinical signs from 1 to 4 dpi,
although a small transient elevation in body temperature was ob-
served at 1 dpi (Fig. 1). The P3 to P6 virus-infected pigs developed
pyrexia (40.0°C) only at 1 dpi (Fig. 1). Strikingly, the P7 to P9
virus-infected pigs showed sustained pyrexia (Fig. 1) accompa-
nied by clear symptoms of depression, anorexia, tremors, and na-
sal and ocular discharge. The P8 virus-infected pigs displayed se-
vere and earlier onset of clinical signs with noticeable wheezing
and coughing at 4 dpi. The P9 virus-infected pigs were the most
severely affected, with the earliest onset of clinical symptoms.
Three control pigs inoculated with SD731 virus (a virulent H1N1/
2009 virus) at 106 TCID50 developed clinical signs (pyrexia,
wheezing, and coughing) from 2 to 4 dpi that were similar to those
observed in the P9 virus-infected pigs.
To examine the pathological effects of multiply passaged
rH1N1 viruses, lungs from infected pigs were examined postmor-
tem. Gross lesions of P1 to P9 virus-infected lungs showed in-
creasing severity (Fig. 2). P1 and P2 virus-infected lungs appeared
normal, but P3 to P8 virus-infected lungs showed increasingmul-
tifocal areas of consolidation in the cardiac, diaphragmatic, and
intermediate lobes. P6 virus-infected lung displayed extensive
hyperemia, edema, and diffuse consolidation over the entire lung
(Fig. 2). P9 virus-infected lung had the most severe lesions with
FIG 1 Passaging of rH1N1 virus in pigs caused progressive body temperature
rise. Rectal temperaturewas taken at two fixed time points daily from0 to 4 dpi
for P1 and P2 (blue), P3 to P6 (orange), P7 to P9, positive-control SD731
virus-inoculated (red), and mock-infected (cyan) pigs. All values shown rep-
resent the mean rectal temperature per day for each animal. A temperature
higher than 39.5°C is considered pyrexic in pigs.
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extensive consolidation in all lobes, which resembled the lung pa-
thology found in SD731 virus-infected pigs (Fig. 2). Microscopic
lesions from P1 to P9 virus-infected lungs increased from mild
bronchitis to severe peribronchiolitis and bronchopneumonia,
which were characterized by edema and diffuse infiltration of in-
flammatory cells in the alveolar lumen and bronchioles (Fig. 2).
The histopathology score of the P9 virus-infected lung was up to
3.5, and those of P6, P3, and P1 virus-infected pigs were up to 3.0,
2.0, and 1.0, respectively (Fig. 3). Together, these findings showed
that the passaging of rH1N1 virus in swine progressively enhanced
its pathogenicity.
To evaluate the ability of each passaged rH1N1 virus to repli-
cate in the pig, we ascertained virus titers of nasal washes, BALF,
and lung tissue at 4 dpi. Titers progressively increased with each
passage; at P9, virus titers were as high as those derived from
SD731 virus-inoculated pigs (P  0.05) (Fig. 4). On the basis of
clinical signs and pathological changes, we concluded that the
rH1N1 virus had acquired an SD731 virus-like pathogenic pheno-
type after nine passages in swine.
Selection of three representative viral clones from P9 quasi-
species. The passaging of IAVs in animals would result in the
natural selection of heterogeneous mixtures of viruses with vari-
ous mutations, the so-called viral quasispecies (23, 24). To assess
possible genetic diversity of viral quasispecies in the upper and
lower respiratory tract of the P9 virus-infected pigs, we per-
formed deep sequencing on viral RNA derived from nasal wash
and BALF. Five consensus mutations were found in the virion
populations of both the nasal wash and BALF compartments
(frequencies of 91%): PB1 A469T, PA I129T, NA N329D,
NS1 N205K, and NEP T48N (Table 1). Mutations detected in
HA showed apparent divergence between the nasal wash and
BALF; D187E, K211E, and S289N mutations were frequent in
the BALF, whereas M227I, S271P, and I295V mutations were
frequent in the nasal wash (Table 1). This HA finding indicates
that the genetic composition of viral quasispecies in the upper
and lower respiratory tract of the P9 virus-infected pigs was
distinctly different. Moreover, within each compartment, the
mutational frequencies of the HA protein ranged from 26.46%
to 55.89% in BALF and 54.72% to 66.35% in nasal wash (Table
1), indicating relatively low mutational consensus in viral pop-
ulations within each location of the airway.
To select representative P9 viral clones from the viral quasispe-
cies, we performed plaque purification and genome sequencing to
establish the sequence composition of individual clones. We iso-
lated randomly 20 lung viral clones (L1 to L20) and 20 nasal viral
clones (N1 to N20) originating from the BALF and nasal wash,
respectively, of the P9 virus-infected pigs. Four of the five consen-
sus mutations (PB1 A469T, NA N329D, NS1 N205K, and NEP
T48N) were identified in all 40 clones, and PA I129T was identi-
fied in 36/40 clones. In contrast, the HA protein showed much
mutational variability (see Table S1 in the supplementalmaterial).
Among all HA mutations in the 20 lung viral clones, D187E,
K211E, and S289N mutations accounted for twelve, five, and
seven mutations, respectively. Most P9 viruses with the D187E
mutation also had the K211E and/or S289N mutation. Con-
FIG 2 Passaging of rH1N1 virus in pigs led to increasing pulmonary damage.
Gross and histopathological examinations were performed on the respiratory
tracts of infected pigs at 4 dpi. Representative gross (left) and corresponding
histological (H&E staining) findings at low (middle) and high (right) magni-
fication are presented. (A and G) P1 virus-infected lung showed mild bron-
chopneumonia with minor lymphocytic infiltration. (B and H) P3 virus-in-
fected lung had moderate bronchopneumonia with inflammatory cell
infiltrates in the alveoli and interstitium (boxed area magnified) and loss of
epithelial lining (black arrow in H). (C and I) P6 virus-infected lung showed
severe bronchopneumonia with hemorrhage, edema, and diffuse consolida-
tion. (D and J) P9 virus-infected lung displayed extensive consolidation in all
lobes and severe bronchopneumonia with diffuse infiltration of neutrophils
and alveolar macrophages (the boxed area is magnified). (E and K) Virulent
SD731 virus-infected lung showed severe bronchopneumonia similar to the
changes found in the P9 lung. (F and L) Mock-infected lung showed normal
morphology. Blue arrows (left) indicate pulmonary tissue consolidation. Re-
sults shown are typical of three independent examinations for each animal.
Scale bar, 200 m.
FIG 3 Histopathological lung lesion scores from progressively passaged
rH1N1 virus-infected pigs at 4 dpi. Microscopic lesions of the cardiac lobes
(black bars) and diaphragmatic lobes (white bars) were evaluated and assigned
a score of 0 to 4 based on evaluation criteria described in Materials andMeth-
ods. All values shown represent the mean score from three independent eval-
uations of each lung. A representative score from SD731 virus-infected lungs
served as a positive control.
Wei et al.
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versely, in the 20 nasal viral clones, mutations M227I, S271P, and
I295V in the HA protein were most frequent, occurring in com-
binations of two (5 clones) or three (10 clones) mutations (see
Table S1).
We next selected three representative viral clones harboring all
five of the consensus mutations (PB1 A469T, PA 1129T, NA
N329D, NS1 N205K, and NEP T48N) in combination with the
D187E, K211E, and S289N mutations (as a representative lower
respiratory tract virus, named L2), with the M227I, S271P, and
I295Vmutations (as a representative upper respiratory tract virus,
named N9), or with no mutational change in the HA (named
L18).
Representative P9 virus-derived viral clones exhibited en-
hanced replication in vitro. To evaluate the replicative abilities of
the L2, N9, and L18 viral clones, they were used to infect MDCK
cells and human A549 cells at anMOI of 0.001 to determine virus
titers over 72 hpi. ForMDCKcells, the titers of the L2,N9, and L18
viruses were higher than those of the parental rH1N1 virus at the
initial 12 to 48 hpi, with significant differences at 12 to 24 hpi (P
0.05) (Fig. 5A). We also assessed the levels of viral nucleoprotein
(NP) inMDCK cells at 12 and 24 hpi. Protein expression of NP by
the three P9 viruses was higher than that of the rH1N1 virus (Fig.
5B). Furthermore, withA549 cells, the titers of the L2,N9, and L18
viruses were significantly higher than those of rH1N1 virus at
almost all time points (P  0.05) (Fig. 5C). These results clearly
demonstrated that the replication of the three P9 viruses in vitro
was significantly greater than that of the parental rH1N1 virus.
PB1 A469Tmutation conferred enhanced polymerase activ-
ity to parental rH1N1 RNP complex. Since there is close correla-
tion between the activity of the viral ribonucleoprotein (RNP)
complex and viral adaptation, replication, and pathogenicity (10,
25), the functional effect of PB1 A469T and PA I129T consensus
mutations on viral polymerase activity was assessed. The polymer-
ase activity of the parental rH1N1 RNP complex was determined
by luciferase assay through cotransfection into 293T cells of ex-
pression plasmids encoding PB2, PB1, PA, and NP, along with
FIG 4 Viral titers in nasal washes, BALFs, and lungs of progressively passaged rH1N1 virus-infected pigs at 4 dpi. Viral titers of nasal washes (A) and BALF (B)
were directly determined by TCID50 assays onMDCK cells. (C) Collected lung tissues were weighed, and 10% (vol/vol) homogenates were prepared in cold PBS.
Virus titers in cleared homogenates were determined by TCID50 assays on MDCK cells. All values shown are means  standard deviations (SD) from three
independent experiments for each sample. Representative SD731 virus titers derived from corresponding sites of infected pigs served as positive controls. An
asterisk indicates that the virus titer was not significantly different from that of the SD731 virus group (P 0.05 by ANOVA). The virus detection limit was 10
TCID50.
TABLE 1 Mutation analysis of viral quasispecies in BALF and nasal wash of P9 virus-infected pigs
Protein
Nucleotide Frequencya (%) in: Position Amino acid
Reference Mutation BALF Nasal wash Nucleotide Amino acid Reference Substitutionc
PB2 A G 50.13 43.12 1185 386 V –
PB1 G A 96.62 95.44 1429 469 A T
PB1 G A 92.50 93.68 204 60 E –
PA T C 95.41 93.15 412 129 I T
HA C A 55.89 ND 644 187 D E
HA A G 26.46 ND 716 211 K E
HA G A 40.23 ND 949 289 S N
HA G A NDb 66.35 764 227 M I
HA T C ND 54.72 894 271 S P
HA A G ND 62.23 966 295 I V
NP G A 27.70 32.46 1413 456 L –
NA A G 91.47 93.67 1005 329 N D
M2 G A 92.06 95.34 313 96 L –
NS1 C A 97.45 96.18 641 205 N K
NEP C A 98.41 97.35 641 48 T N
a All mutations shown have a frequency of10%.
b ND, not detected.
c –, silent substitution.
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luciferase reporter pYH-Luci plasmid and an internal renilla con-
trol plasmid (Fig. 6). The replacement of parental PA with PA
I129T plasmid had little effect on RNP activity. However, replace-
ment of parental PB1 with PB1 A469T plasmid resulted in about a
6-fold increase in polymerase activity (P  0.05) (Fig. 6). This
result indicates that PB1 A469T is an important contributor to the
enhanced replicative ability of P9 viruses.
Representative P9-derived viruses exhibited enhanced patho-
genicityandtransmissibility in swine.To assess the pathogenicity
of the three representative P9 virus-derived viral clones (L2,
N9, and L18 viruses) in relation to parental rH1N1 virus in
vivo, each group of three pigs was infected intranasally with
each virus at 106 TCID50. At 1 dpi, three naive in-contact pigs
were added to each infected group. All pigs directly infected
with L2, N9, and L18 viruses showed typical flu-like symptoms
(i.e., pyrexia, depression, nasal discharge, wheezing, and
coughing) associated with moderate to severe lung lesions, and
most in-contact pigs in these three groups also displayed mild
pyrexia, nasal discharge, and similar pathological damage (Ta-
ble 2 and Fig. 7). In contrast, the rH1N1-inoculated and in-
contact pigs showed no obvious clinical symptoms and pulmo-
nary damage (Table 2 and Fig. 7). Pathological lung scores were
2.8  0.1, 2.5  0.1, and 2.3  0.3 in the L2, N9, and L18
directly infected groups, respectively, which were significantly
higher than the scores of the rH1N1 inoculated pigs (0.3 0.1;
P  0.05).
Virus shedding or presence wasmonitored fromnasal swabs of
directly infected pigs from 1 to 6 dpi and of in-contact pigs from 1
to 7 dpc. Viral shedding was detected in all pigs directly infected
with L2,N9, L18, and rH1N1 viruses at 1 to 6 dpi. Peak titers of the
three P9 viruses were approximately 10-fold higher than those of
the rH1N1 virus (Fig. 8). Notably, all L2, N9, and L18 in-contact
pigs shed virus, but no virus was detected in rH1N1 in-contact
pigs throughout the screening period (Fig. 8). Together, these data
indicate that the pathogenicity and transmissibility of P9 virus-
FIG 5 Three representative P9 viral clones exhibited enhanced replication in MDCK and A549 cells. Viable virus output from MDCK (A) or A549 (C) cells
infected with three viruses derived from the P9 infection (L2, N9, and L18) and parental rH1N1 viruses, at anMOI of 0.001, was determined by TCID50 assay at
12, 24, 36, 48, 60, and 72 hpi. The values are expressed as means SD (n 3). An asterisk indicates that the value of the corresponding virus was significantly
different from that of the rH1N1 virus (P 0.05 by ANOVA). (B) Western blots for viral NP detection in MDCK cells at 12 and 24 hpi; 	-actin was used as a
loading control. The Western blot results are representative of three independent experiments.
FIG 6 Activity of parental rH1N1 RNP complex reconstituted with P9 virus-
derived PA I129T and PB1 A469T mutants. A combination of four plasmids
expressing RNP components of parental rH1N1 virus (PB2, PB1, PA, andNP),
luciferase reporter plasmid pYH-Luci, and an internal renilla control plasmid
were transfected into 293T cells. Mutant PA I129T or PB1 A469T plasmid was
substituted for the correspondingwild-type rH1N1plasmids as indicated. Val-
ues shown representmeans SD for three independent experiments, normal-
ized to the activity of parental rH1N1 RNP complex (100%). *, P  0.05
compared to the correspondingly transfected rH1N1 response.
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derived L2,N9, and L18 viruses weremuch greater than that of the
parental rH1N1 virus.
Representative P9 virus-derived viruses also acquired in-
contact transmissibility in guinea pigs.Our previous study dem-
onstrated that the parental rH1N1 virus is not transmissible be-
tween guinea pigs, unlike the pandemic H1N1/2009 virus, which
transmits efficiently in these animals (7). To determine whether
the passaged virus had acquired this transmissibility, guinea pigs
were infected with the P9 virus-derived L2, N9, L18, or parental
rH1N1 virus. Consistent with previous findings (7), there was no
virus shedding from in-contact guinea pigs in the rH1N1 group
(Fig. 9D). However, two of three guinea pigs in contact with
guinea pigs directly infected with L2, N9, and L18 viruses devel-
oped virus shedding (Fig. 9A to C), which suggests that these vi-
ruses have largely acquired the ability to transmit infection to
in-contact guinea pigs.
Mutation PB1 A469T, and single-site combined mutations
NS1 N205K and NEP T48N, in rH1N1 virus conferred in-con-
tact transmissibility in guinea pigs.Among the three transmissi-
ble P9 virus-derived clones, L18 virus contains the five consensus
amino acid mutations with no change in HA in relation to the
parental rH1N1 virus. To further determine which amino acid
mutation contributes to the contact transmissibility of P9-derived
viruses, we performed reverse genetics to construct four single-
site mutant viruses from rH1N1, named PB1 A469T, PA I129T,
NA N329D, and NS1 N205K-NEP T48N (derived from a one-
nucleotide change), and two double-site mutant viruses (named
PB1 A469T-PA I129T and NA N329D-NS1 N205K-NEP T48N).
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FIG 7 Gross pathology and histopathology of lungs from pigs infected with
three representative P9-derived viruses. Lungs were isolated from pigs directly
infectedwith the L2, N9, L18, and control parental rH1N1 viruses at 6 dpi or as
in-contacts at 8 dpi (7 dpc). (A to C) Lungs from directly infected L2, N9, and
L18 viruses showed moderate pulmonary consolidation (white arrows) and
moderate to severe bronchopneumonia with interstitial pulmonary edema
and inflammatory cell infiltrates in alveolar space. (E to G) Lungs from in-
contact pigs exposed to L2, N9, and L18 viruses also showedmild lung consol-
idation (white arrows) and mild to moderate bronchopneumonia. (D and H)
There was no apparent pathological damage detected in lungs of rH1N1-in-
fected and in-contact pigs. Images shown are representative of three pigs from
three independent experiments. Scale bar, 200 m.
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Among these six viruses, the PB1 A469T-only mutation infected
one of three contact guinea pigs (Fig. 10A and E), andNS1N205K
and NEP T48N mutation infected two of three contact animals
(Fig. 10D and F). However, no virus shedding was detected in any
contact animals from the PA I129T and NA N329D groups (Fig.
10B and C). These results indicated that PB1 A469T, combined
NS1 N205K and NEP T48N single-site mutations in the parental
rH1N1 virus, conferred enhanced in-contact transmissibility in
guinea pigs. Additionally, virus output from these transmissible
rH1N1mutants at 5.75 to 7.25 log10 TCID50/ml (Fig. 9B to D and
10A andD to F)was significantly higher than that of the nontrans-
missible rH1N1 mutants at 4.25 to 5.75 log10 TCID50/ml (Fig. 9A
and 10B and C) (P 0.05), which suggested that the transmissi-
bility of mutant PB1 A469T and combined mutant NS1 N205K
and NEP T48N in guinea pigs also was related to enhanced virus
replication. No obvious clinical signs were observed in any of the
infected and uninfected guinea pigs during the observation pe-
riod, and all animals with viral shedding also showed seroconver-
sion (data not shown).
Severe pathogenicity and respiratory droplet transmission
of representative P9-derived viruses in ferrets. Ferrets have been
widely used as an experimental model to study human infection
and transmission of influenza virus (13, 26). Three ferrets were
infected intranasally with each virus (L2, N9, L18, and parental
rH1N1 viruses) at a dose of 106 TCID50. Directly infected ferrets
were individually caged and sited in close proximity to individu-
ally kept naive ferrets (5 cm away).
All ferrets directly infected with P9 virus-derived L2, N9, and
L18 viruses developed severe clinical symptoms (pyrexia, lethargy,
anorexia, sneezing, wheezing, and coughing) from 2 to 8 dpi, in-
cluding one death fromL2 virus infection at 7 dpi (Table 3). How-
ever, all rH1N1 virus-infected ferrets developed only mild clinical
signs of slight pyrexia, anorexia, and sneezing at 2 to 4 dpi (Table
3). At postmortem at 8 dpi, gross and histopathological lesions,
including severe consolidation (40%), hemorrhage, and edema,
were evident in all ferrets infected with the three P9-derived vi-
ruses. In contrast, little or no lung consolidation (0% to 5%) was
found in parental rH1N1 virus-infected ferrets (Fig. 11 and Table
3). These results demonstrate that the three P9-derived viruses
(L2, N9, and L18) were much more pathogenic than the parental
rH1N1 virus in ferrets.
To assess the transmissibility of the P9-derived viruses in fer-
rets, we compared virus titers in nasal washes from directly in-
fected and proximally exposed ferrets. High levels of virus shed-
ding were evident for all directly infected ferrets (6.25 log10
TCID50/ml at 2 to 4 dpi), which was about 10- to 100-fold greater
than that of the corresponding rH1N1 virus group (Fig. 12).How-
ever, for proximally exposed ferrets, only the group associated
with the L2 virus was found to shed virus continuously in all three
exposed ferrets and at levels comparable to that of the directly
infected ferrets (Fig. 12A). Notably, the high levels of L2 virus
replication in directly infected and proximally exposed ferrets
were highly similar to corresponding reported findings of H1N1/
2009 viruses (27, 28). Additionally, all proximally exposed L2 fer-
rets showed severe clinical signs and pulmonary damage (Fig. 11
and Table 3). Taken together, these results demonstrate that the
three representative P9-derived viruses (L2, N9, and L18) had ac-
quired enhanced replication and pathogenicity in ferrets, and that
L2 virus additionally was highly effective in airborne transmission
in ferrets. The latter finding suggests that the HA mutations
FIG 8 In-contact transmission of viruses derived from P9 virus-derived L2, N9, and L18 viruses in pigs. Groups of three pigs (4 to 5 weeks old) were infected
intranasally with 106 TCID50 of L2 (A), N9 (B), L18 (C), and parental control rHIN1 (D) viruses. Three naive animals were introduced into each group 24 h later.
Unlike parental rH1N1 virus, all three P9-derived viruses were efficiently transmitted to all in-contact pigs. Virus titers in nasal swabswere determined byTCID50
assays onMDCK cells at the indicated dpi or dpc. The horizontal dashed line corresponds to the TCID50 assay detection limit. Each bar represents the virus titer
from an individual animal.
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(D187E, K211E, and S289N) in the L12 virus contribute to its
airborne transmission ability.
DISCUSSION
The pandemic H1N1/2009 virus is thought to have been gen-
erated in swine and circulated in pig populations before its
cross-species transmission to humans; however, despite con-
siderable research, this has not been proven (2, 3, 6). Here, we
serially passaged an engineered H1N1/2009-like precursor
(rH1N1) virus in pigs to simulate a probable evolutionary
emergence route of the H1N1/2009 virus. Dramatic changes in
viral characteristics occurred after just nine serial passages, in-
cluding enhanced replication and polymerase activity in vitro,
increased pathogenicity in pigs and ferrets, and efficient in-
contact transmission in pigs and guinea pigs. Furthermore, a
P9-derived clone (L2 virus) even acquired highly efficient re-
spiratory droplet transmissibility in ferrets, a property which
was similar to that of the H1N1/2009 virus.
Adaptation is believed to be a driving force in evolution,
whereby organisms, including viruses, are selected in nature be-
cause of increased fitness conferred by gene mutations (24). For
IAVs, adaptive evolution does not act on a single virion but on
quasispecies, which represent populations of diverse variants that
are genetically similar and collectively contribute to the character-
istics of the population (24, 29). Here, we used deep sequencing to
examine the mutations and frequency of the viral quasispecies in
the upper (nasal wash) and lower (BALF) respiratory tracts of the
P9 virus-infected pigs. We found five consensus amino acid mu-
tations in all of the quasispecies in both compartments, indicating
rapid mutational selection in limited serial passages. However,
mutations in the HA gene exhibited marked differences between
nasal wash and BALF, revealing evolutionary divergence of HA
genes between upper and lower airways within an animal. The
cause for this mutational divergence could be related to the virus
itself, cell surface receptors, cell types, and antibody binding (30–
32). Moreover, the frequencies of HA mutations varied in the
upper and lower respiratory tracts. This finding was verified by
sequencing single viral clones, which reflected complex combina-
tions of dominant and/or sporadic mutations in HA proteins
within each location of the airway (see Table S1 in the supplemen-
tal material). This phenomenon shares some similarities with the
findings of Murcia et al. (33) with regard to the evolutionary dy-
namics of a Eurasian avian-like swine influenza virus along the
natural transmission chain. They observed a highly dynamic mu-
tational spectrum with both transient and fixed mutations in the
HA gene derived from consecutive daily nasal virus populations.
We speculate that there are two kinds of evolutionary processes at
work in the convergent evolution of influenza virions, high-fre-
quency mutagenesis and rapid allele fixation, and such an evolu-
tionary scheme readily facilitates IAV infection and transmission
in new host species.
Most reported triple-reassortant swine H1 viruses causedmild
disease, were inefficiently transmitted through the air in ferrets
(34, 35), and had restricted circulation in humans (36), even
though they generally possess strong binding affinity for the 
2,6-
linked human-like receptor (37). Our previous (7) and present
studies demonstrated that the parental rH1N1 virus had viral
characteristics identical to those of these reported triple-reas-
FIG 9 In-contact transmission of P9 virus-derived L2, N9, and L18 viruses in guinea pigs. Four groups of guinea pigs (three to a group) each were intranasally
inoculated with 106 TCID50 of L2 (A), N9 (B), L18 (C), or rHIN1 (D) virus. At 1 dpi, each directly infected animal (individually housed) was moved to another
cage holding a naive guinea pig. Viral titers of daily nasal washeswere determined byTCID50 assays onMDCKcells from the directly infected (squareswith dotted
lines) and in-contact guinea pigs (triangles with solid lines) and are presented as a function of days postvirus inoculation. Two out of three in-contact guinea pigs
for each P9-derived virus showed virus shedding. There was no detectable rH1N1 virus shedding from in-contact guinea pigs. The virus detection limit was 10
TCID50.
Adaptive Evolution of Inﬂuenza A Virus in Swine
October 2014 Volume 88 Number 20 jvi.asm.org 11989
 o
n
 June 30, 2017 by Univ of Nottingham
http://jvi.asm.org/
D
ow
nloaded from
 
sortant viruses. Crucially, we found that by passage nine in pigs,
the replication and pathogenicity of three representative mutants
(L2, N9, and L18) greatly exceeded those of the parental rH1N1
virus in both pigs and ferrets. More importantly, the three viruses
had enhanced contact transmissibility in both pigs and guinea
pigs. Their enhanced virulence and contact transmissibility were
similar to that of the H1N1/2009 virus (38–40). Since the viru-
lence and contact transmissibility were comparable between the
L2, N9, and L18 viruses, these acquired traits were determined
primarily by the five consensusmutations (PB1 A469T, PA I129T,
NA N329D, NS1 N205K, and NEP T48N) found in all three virus
species. Furthermore, guinea pig experiments demonstrated that
the PB1 A469Tmutation and the combined NS1N205K andNEP
T48Nmutations in rH1N1 virus conferred in-contact transmissi-
bility in guinea pigs.
Viral polymerase may be the driving component of early evo-
lution of an IAV in a new host, and polymerase-enhancing muta-
tions could contribute to the increased replication and virulence
of IAVs (10, 25, 41).Weobserved significantly enhanced polymer-
ase activity with the PB1 A469T mutation in the parental rH1N1
RNP complex. Residue position 469 locates to a site involved in
RNApolymerase activity (42), and sequence analysis revealed that
PB1 469T is conserved in pandemic H1N1/2009 isolates, which
could be an important pathogenicity determinant of the pan-
demicH1N1/2009 virus. Our previous studies have demonstrated
that the NS gene of H1N1/2009 origin is critical for contact trans-
mission of the rH1N1 virus in guinea pigs (7). Zhang et al. have
reported that the NS gene of H1N1/2009 virus can confer H5N1
virus transmission by respiratory droplet between guinea pigs
(43). For the combined NS1N205K andNEP T48Nmutant virus,
we could not readily verify which one of the two proteins plays a
major role in guinea pig transmissibility, as both changes are the
result of a single-nucleotide change.We do know thatNS1 protein
of IAV is a multifunctional virulence factor that inhibits host cell
pre-mRNA processing and counteracts host cell antiviral re-
sponses. Residue 205 is located in the C terminus (residues 201 to
230) of NS1, and this tail has been implicated in the interaction of
NS1 with cleavage and polyadenylation specificity factor (CPSF),
poly(A)-binding protein II (PAB II), and host importins (44–46).
It is likely that the NS1 N205Kmutation plays a role in the patho-
genesis of IAV by influencing these interactions. NEP, formerly
called NS2, has been demonstrated to mediate the export of viral
RNP complexes from the nucleus (47) and to act as a quantitative
switch from viral transcription during early viral replication to
favor late-stage production of genomic vRNPs (48). Additionally,
NEP also has been implicated in recruiting a cellular ATPase to the
cell membrane to aid the efficient release of budding virions (49,
50). Accordingly, NEP is proposed to play multiple biologically
important roles during the life cycle of IAVs; thus, NEP T48N
mutation could alter the replication and transmission character-
istics of the rH1N1 virus.
A hallmark of the pandemic H1N1/2009 virus is its efficient
transmission in humans (51, 52). In the present study, we found
that the P9-derived L2 virus was efficiently transmitted through
the air in ferrets (a recognized model of human influenza virus
infection), as observed with the pandemic H1N1/2009 virus (27,
28). This suggests that the five consensus mutations are responsi-
ble for the enhanced virulence, and that the HA mutations
(D187E, K211E, and S289N) in the L2 virus are linked to effective
airborne transmission in ferrets. The receptor binding specificity
FIG 10 In-contact transmission of mutant rH1N1 viruses in guinea pigs. Guinea pigs (in six groups of three) each were intranasally inoculated with 106 TCID50
of PB1 A469T (A), PA I129T (B), NAN329D (C), the combined NS1 N205K and NEP T48N (NS1 N205K &NEP T48N) (D), the combined PB1 A469T and PA
I129T (PB1A469TPA I129T) (E), or the combinedNAN329D,NS1N205K, andNEPT48N (NAN329DNS1N205K&NEPT48N) (F) virus. At 1 dpi, each
directly infected animal (individually housed)wasmoved to another cage holding a naive guinea pig. Viral titers of daily nasal washeswere determined byTCID50
assays onMDCK cells from the directly infected (squares with dotted lines) and in-contact guinea pigs (triangles with solid lines) and are presented as a function
of days postvirus inoculation. Infections with the PB1 A469T mutant and combined NS1 N205K and NEP T48N mutant viruses were transmissible to one and
two in-contact guinea pigs, respectively. The virus detection limit was 10 TCID50.
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of HA has been implicated in interspecies transmission of IAVs
(53, 54). Binding to the 
2,6-linked sialic acid receptor is thought
to be a critical prerequisite for IAVs to cross the species barrier and
to adapt to the human host (55, 56). We also determined the
receptor-binding properties of the three P9-derived viral clones
using direct glycan receptor-binding assays and found that all
three P9-derived viruses retained the 
2,6-linked receptor
binding specificity of the parental rH1N1 virus (data not
shown). Hence, 
2,6-linked receptor binding specificity alone
could not mediate airborne transmission. We surmise that the
three mutations in HA of L2 virus play a role in its function
after cell entry, such as in its acid stability, which is associated
with the conformational change of HA and fusion of the viral
and endosomal membranes in the release of the virus genome
into the cytoplasm (57). Further study will be needed to exam-
ine the critical genetic changes in airborne L2 virus, especially
those in the HA protein.
Finally, the identified mutations (except for the PB1 A469T
mutation), linked to enhanced pathogenicity and transmissibility
(in-contact and aerosol spread), which arose from serial passage in
pigs, were not found in the H1N1/2009 virus. These mismatches
are not entirely surprising, as there are about 180 amino acid dif-
ferences between the parental rH1N1 virus and the early pan-
demic H1N1/2009 virus. Such differences suggest that gain in
pathogenicity and transmissibility can be achieved through differ-
ent combinations of amino acid changes in the virus. We demon-
strated that pigs can independently facilitate such combinatorial
changes in the genesis of a potential human pandemic strain for
which all gene segments are of swine origin. Therefore, it would
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FIG 11 Gross pathology and histopathology of lungs from ferrets infected
with three representative P9-derived viruses (L2, N9, and L18). Lungs were
isolated from ferrets directly infected with L2, N9, L18, and rH1N1 viruses at 8
dpi or from ferrets proximally exposed for 9 days (10 dpi) to infected ones. (A
to C and E) Lungs from pigs directly infected L2, N9, and L18 viruses, along
with lungs of L2 virus-exposed pigs, showed extensive edema, consolidation
(white arrows), severe interstitial pneumonia with infiltration of erythrocytes,
and inflammatory cells in the alveolar space. (D) The directly infected rH1N1
lung showedmild edema, emphysema, andmild bronchopneumonia. (F toH)
Lungs of ferrets proximally exposed to ferrets directly infected with N9, L18,
and rH1N1 viruses showed no obvious gross lesions or pathological damage.
Images shown are representative of three ferrets from three independent ex-
periments. Scale bar, 200 m.
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have been highly feasible for the generation of the emergent pan-
demic virus to have begun in swine, althoughwe are still unable to
determine whether other host species were involved in the evolu-
tion of pandemicH1N1/2009 virus prior to its jump into humans.
Altogether, our findings emphasize the importance of continued
monitoring of influenza viruses in pigs.
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